We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+14.31%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$16.1B
AUM Growth
+$2.04B
Cap. Flow
-$98.3M
Cap. Flow %
-0.61%
Top 10 Hldgs %
35.04%
Holding
1,426
New
99
Increased
660
Reduced
349
Closed
106

Top Buys

Rank Stock Value
1
IRM icon
Iron Mountain
IRM
+$97M
2
VICI icon
VICI Properties
VICI
+$80.3M
3
ESS icon
Essex Property Trust
ESS
+$78.8M
4
WPC icon
W.P. Carey
WPC
+$61.7M
5
IBN icon
ICICI Bank
IBN
+$28M

Sector Composition

Rank Sector Weight
1 Real Estate 52.1%
2 Technology 13.53%
3 Consumer Discretionary 4.91%
4 Financials 4.82%
5 Healthcare 4.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CBAY
1151
DELISTED
Cymabay Therapeutics
CBAY
$11K ﹤0.01%
464
+123
+36% +$2.19K
ACLX
1152
DELISTED
Arcellx
ACLX
$10K ﹤0.01%
176
CACI icon
1153
CACI
CACI
$10.9B
$10K ﹤0.01%
30
-4,398
-99% -$1.43M
CRNX icon
1154
Crinetics Pharmaceuticals
CRNX
$8.88B
$10K ﹤0.01%
273
+74
+37% +$2.27K
RYTM icon
1155
Rhythm Pharmaceuticals
RYTM
$7.36B
$10K ﹤0.01%
227
GHC icon
1156
Graham Holdings Company
GHC
$5.33B
$9K ﹤0.01%
13
-9
-41% -$5.6K
IDYA icon
1157
IDEAYA Biosciences
IDYA
$3.46B
$9K ﹤0.01%
264
+71
+37% +$2.12K
IMCR icon
1158
Immunocore
IMCR
$1.69B
$9K ﹤0.01%
138
+34
+33% +$1.77K
PACB icon
1159
Pacific Biosciences
PACB
$435M
$9K ﹤0.01%
909
RCKT icon
1160
Rocket Pharmaceuticals
RCKT
$336M
$9K ﹤0.01%
304
SWTX
1161
DELISTED
SpringWorks Therapeutics
SWTX
$9K ﹤0.01%
251
ARVN icon
1162
Arvinas
ARVN
$530M
$8K ﹤0.01%
198
BEAM icon
1163
Beam Therapeutics
BEAM
$2.71B
$8K ﹤0.01%
283
CVLT icon
1164
Commault Systems
CVLT
$5.04B
$8K ﹤0.01%
+100
New +$7.15K
HRMY icon
1165
Harmony Biosciences
HRMY
$2.07B
$8K ﹤0.01%
239
PTCT icon
1166
PTC Therapeutics
PTCT
$6.17B
$8K ﹤0.01%
289
TWST icon
1167
Twist Bioscience
TWST
$5.34B
$8K ﹤0.01%
210
SAVE
1168
PUT
DELISTED
Spirit Airlines, Inc.
SAVE
$8K ﹤0.01%
+100
New +$1.44K
ABCL icon
1169
AbCellera Biologics
ABCL
$1.67B
$7K ﹤0.01%
1,151
DVAX
1170
DELISTED
Dynavax Technologies
DVAX
$7K ﹤0.01%
+529
New +$7.35K
IOVA icon
1171
Iovance Biotherapeutics
IOVA
$2.07B
$7K ﹤0.01%
877
PRTA icon
1172
Prothena Corp
PRTA
$441M
$7K ﹤0.01%
195
SMMT icon
1173
Summit Therapeutics
SMMT
$9.83B
$7K ﹤0.01%
2,728
VCEL icon
1174
Vericel Corp
VCEL
$2.35B
$7K ﹤0.01%
+195
New +$6.79K
VCYT icon
1175
Veracyte
VCYT
$4.43B
$7K ﹤0.01%
266

Similar funds

Daiwa Securities Group's Q4 2023 Portfolio in Review

As of Q4 2023, Daiwa Securities Group held 1,426 positions worth $16.1B, up 15% from $14B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Daiwa Securities Group's Q4 2023 filing shows 99 new, 660 increased, 349 reduced and 106 closed positions. Its largest new stake was Veralto: 45,224 shares worth $3.72M. The largest sale was Mid-America Apartment Communities, an estimated $128M.

By sector, the portfolio is most concentrated in Real Estate at 52% of assets, down from 53% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Daiwa Securities Group's largest Q4 2023 buy was Veralto: 45,224 shares worth $3.72M.
  • Daiwa Securities Group added most to Iron Mountain in Q4 2023, an estimated $97M increase.
  • Daiwa Securities Group's biggest Q4 2023 reduction was Mid-America Apartment Communities, cutting an estimated $128M.
  • Daiwa Securities Group fully exited Activision Blizzard in Q4 2023, selling an estimated $6.04M.
  • Daiwa Securities Group's ten largest holdings make up 35% of its $16.1B portfolio in Q4 2023.
  • Daiwa Securities Group opened 99 new positions and closed 106 in Q4 2023.
  • Daiwa Securities Group's portfolio value rose 15% quarter-over-quarter to $16.1B.

Based on Daiwa Securities Group's 13F filing for Q4 2023, filed 31 Jan 2024.